Condition
Relapsed Ovarian Cancer clinical trials and research
Research outlook What's coming for Ovarian cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 2 Relapsed Ovarian Cancer clinical trials that are recruiting, at sites in 2 countries (most in China (1), United Kingdom (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Comparing secondary surgery plus chemotherapy to chemotherapy alone for relapsed ovarian cancer after PARPi treatment
This study is testing whether adding surgery to chemotherapy helps women with relapsed ovarian cancer feel better compared to just getting chemotherapy alone after they've been on a specific treatment.
-
Adaptive chemotherapy approach for relapsed ovarian cancer
This study is testing if adjusting the dose of carboplatin based on a blood marker can help women with relapsed ovarian cancer feel better and have fewer side effects from treatment.
Related topics
Quick answers
How many Relapsed Ovarian Cancer clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.